BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Carl Zeiss to Acquire Xradia for Undisclosed Amount


6/14/2013 6:57:16 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ZEISS to Acquire Xradia to Complement Its Microscopy Business

OBERKOCHEN, GERMANY and PLEASANTON, CA--(Marketwired - Jun 13, 2013) - ZEISS, the international leader in the fields of optics and optoelectronics, today announced the planned acquisition of the US-based Xradia, Inc. Xradia is a medium-size company providing innovative 3D X-ray microscopes for industrial and academic research applications. The closing of the transaction is subject to the fulfillment of customary closing conditions including a required filing with the U.S. competition authorities. After closing, Xradia, Inc. will operate under the new name Carl Zeiss X-ray Microscopy, Inc.

X-ray microscopes help to advance innovation in science and industry and can be used for many applications. During the last years Xradia recorded strong growth in revenue, profits, and number of employees based on its excellent technology position meeting customer needs worldwide. Xradia has become a provider of established solutions for advanced material research, natural resources and geology, semiconductor process optimization as well as the life sciences. Both parties have agreed to keep the purchase price confidential.

"For ZEISS the microscopy business is a strong pillar in its portfolio. The investment in Xradia underlines our strategy to grow with the most innovative and future-oriented technologies," stated Dr. Michael Kaschke, President and CEO of Carl Zeiss AG. "The decision to acquire Xradia was made after careful consideration of its product lines as well as sales and service coverage. By combining the product lines, ZEISS will be able to better serve the growing demands in multimodal microscopic imaging and to develop solutions which create new values for our customers in science and industry."

Dr. Ulrich Simon, head of the ZEISS Microscopy business group, further said, "This step is extremely exciting for us as it demonstrates our clear focus to take microscopy to the next level. Based on our unique portfolio of light, electron and ion microscopes, we are now adding the capability of 3D imaging within objects at unprecedented resolution using X-ray microscopy. This will enable new applications and make the workflows in multimodal imaging easier and more efficient to use for our customers worldwide."

Rod Browning, President and CEO of Xradia, Inc., adds, "We could not be more pleased than to join such an outstanding and well-regarded global organization as ZEISS. Xradia's significant growth over the past years demonstrates the value of high resolution 3D X-ray microscopy for researchers worldwide. The additional resources offered by ZEISS will undoubtedly facilitate even more rapid growth of X-ray microscopy solutions as well as provide additional value for our existing customer base."

Carl Zeiss Group

The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company's approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, Carl Zeiss has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. Carl Zeiss is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

Microscopy Business Group

The Microscopy business group at ZEISS is the world's only provider of both light and electron microscopes. The company's extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites can be found in Oberkochen, Göttingen and Munich, as well as in the UK and the USA. The business group has around 2,800 employees and generates revenue of EUR 650 million.

Xradia

Xradia designs and manufactures 3D X-ray microscopes for industrial and academic research applications. Xradia's solutions offer unparalleled high contrast and high resolution imaging capabilities for a large range of sample sizes and shapes. Xradia's laboratory product families, the UltraXRM® and VersaXRM® X-ray microscopes, together offer a multi-length scale solution delivering full volume 3D imaging with resolution down to

Contact:

Press contact ZEISS

Jorg Nitschke

Carl Zeiss, Corporate Communications

Group Spokesman

Phone +49 7364 20-3242

Email: Email Contact

Dr. Jochen Tham

Carl Zeiss, Microscopy

Phone +49 3641 64-3949

Email: Email Contact

Press contact Xradia

Brenda Ropoulos

Corporate Communications Xradia

Phone +1.510.414.6772

Email: Email Contact

www.zeiss.de/press

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

Carl Zeiss
Xradia
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->